Half-dose photodynamic therapy offers robust anatomic improvement for patients with acute central serous chorioretinopathy.

Researchers sought to determine if HRQoL measures differ with gilteritinib compared with placebo in patients with AML.

Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic ...

A case study published by researchers at Johns Hopkins University showed that optical genome mapping (OGM) detected a structural variant that was ...

The trial is designed to assess the tolerability, efficacy, and safety of two different dosages of the therapy.

The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...

West Virginia University pediatric trauma specialists and statisticians have formulated a measure to more accurately assess ...

The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...

Recombinant human prourokinase is noninferior to alteplase and associated with decreased bleeding risks among patients with acute ischemic stroke, a new trial showed.

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.

Sepsis, a severe and often fatal complication of infection, is a leading cause of both ALI and acute respiratory distress ...